European CRO Clinscience has acquired CRO Experior, to increase its global capabilities. For 20 years, Experior has activities Spain, Italy, Portugal, France, the UK and the Benelux countries, with a oncology, neurology, infectious and autoimmune diseases, and a knowledge of the development of research projects in the field of ATMP - advanced medical technologies. In a statement, the merger complements both companies in terms of competences and geographical range, and continues the qualities of building value for our clients, focusing attention around the patient, and service technology.
For more information, click here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma
July 22nd 2025The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (NCT03767348) trial in advanced melanoma was not an adequate, well-controlled study and that its heterogeneous patient population limited interpretability, preventing approval in its current form.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.